GlycoMimetics, Inc.
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inh…
Biotechnology
US, Rockville [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
GlycoMimetics, Inc. has no acquisition track records yet.
M&A Deals · History
GlycoMimetics, Inc. has no acquisition track records yet.